Health Resources and Services Administration, ?Organ Procurement and Transplant Network Database,
?
Lentine ?K.L., Brennan ?D.C., Schnitzler ?M.A..?Incidence and predictors of myocardial infarction after kidney transplantation,
?
Kasiske ?B.L., Maclean ?J.R., Snyder ?J.J..?Acute myocardial infarction and kidney transplantation,
?
Lentine ?K.L., Schnitzler ?M.A., Abbott ?K.C.. ?et al.??De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications,
?
Lentine ?K.L., Schnitzler ?M.A., Abbott ?K.C.. ?et al.??Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation,
?
Ramanathan ?V., Goral ?S., Tanriover ?B.. ?et al.??Screening asymptomatic diabetic patients for coronary artery disease prior to renal transplantation,
?
Fleisher ?L.A., Beckman ?J.A., Brown ?K.A.. ?et al.??ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery),
?
Hendel ?R.C., Berman ?D.S., Di Carli ?M.F.. ?et al.??ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine,
?
Poldermans ?D., Schouten ?O., Vidakovic ?R.. ?et al.??A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study,
?
McFalls ?E.O., Ward ?H.B., Moritz ?T.E.. ?et al.??Coronary-artery revascularization before elective major vascular surgery,
?
Schouten ?O., van Kuijk ?J.P., Flu ?W.J.. ?et al.??Long-term outcome of prophylactic coronary revascularization in cardiac high-risk patients undergoing major vascular surgery (from the randomized DECREASE-V Pilot Study),
?
K/DOQI Workgroup, ?K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients,
?
Abbud-Filho ?M., Adams ?P.L., Alberu ?J.. ?et al.??A report of the Lisbon Conference on the care of the kidney transplant recipient,
?
Kasiske ?B.L., Cangro ?C.B., Hariharan ?S.. ?et al.??The evaluation of renal transplantation candidates: clinical practice guidelines,
?
EBPG Expert Group on Renal Transplantation, ?European best practice guidelines for renal transplantation,
?
Ferreira ?S.R., Moises ?V.A., Tavares ?A., Pacheco-Silva ?A..?Cardiovascular effects of successful renal transplantation: a 1-year sequential study of left ventricular morphology and function, and 24-hour blood pressure profile,
?
Ramos ?E.L., Kasiske ?B.L., Alexander ?S.R.. ?et al.??The evaluation of candidates for renal transplantation: the current practice of U.S. transplant centers,
?
Danovitch ?G.M., Hariharan ?S., Pirsch ?J.D.. ?et al.??Management of the waiting list for cadaveric kidney transplants: report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation,
?
Zarifian ?A., O'Rourke ?M..?Managing the kidney waiting list,
?
Lentine ?K.L., Schnitzler ?M.A., Brennan ?D.C.. ?et al.??Cardiac evaluation before kidney transplantation: a practice patterns analysis in Medicare-insured dialysis patients,
?
Weng ?F.L., Joffe ?M.M., Feldman ?H.I., Mange ?K.C..?Rates of completion of the medical evaluation for renal transplantation,
?
Kressin ?N.R., Petersen ?L.A..?Racial differences in the use of invasive cardiovascular procedures: review of the literature and prescription for future research,
?
Friedman ?S., Palac ?R., Chobanian ?M., Costa ?S..?A Call to Action: variability in guidelines for cardiac evaluation prior to renal transplantation,
?
Kasiske ?B.L., Malik ?M.A., Herzog ?C.A..?Risk-stratified screening for ischemic heart disease in kidney transplant candidates,
?
Lewis ?M.S., Wilson ?R.A., Walker ?K.. ?et al.??Factors in cardiac risk stratification of candidates for renal transplant,
?
Patel ?A.D., Abo-Auda ?W.S., Davis ?J.M.. ?et al.??Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation,
?
Patel ?R.K., Mark ?P.B., Johnston ?N.. ?et al.??Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-center prospective observational study,
?
Boden ?W.E., O'Rourke ?R.A., Teo ?K.K.. ?et al.??Optimal medical therapy with or without PCI for stable coronary disease,
?
Sedlis ?S.P., Jurkovitz ?C.T., Hartigan ?P.M.. ?et al.??Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease,
?
Eagle ?K.A., Guyton ?R.A., Davidoff ?R.. ?et al.??ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery),
?
Hillis ?L.D., Smith ?P.K., Anderson ?J.L.. ?et al.??2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,
?
Port ?F.K., Wolfe ?R.A., Mauger ?E.A.. ?et al.??Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients,
?
Merion ?R.M., Ashby ?V.B., Wolfe ?R.A.. ?et al.??Deceased-donor characteristics and the survival benefit of kidney transplantation,
?
Gill ?J.S., Tonelli ?M., Johnson ?N.. ?et al.??The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation,
?
Jeloka ?T.K., Ross ?H., Smith ?R.. ?et al.??Renal transplant outcome in high-cardiovascular risk recipients,
?
Frank ?S.M., Beattie ?C., Christopherson ?R.. ?et al.??Perioperative rate-related silent myocardial ischemia and postoperative death,
?
Landesberg ?G., Luria ?M.H., Cotev ?S.. ?et al.??Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery,
?
Landesberg ?G., Mosseri ?M., Wolf ?Y.. ?et al.??Perioperative myocardial ischemia and infarction: identification by continuous 12-lead electrocardiogram with online ST-segment monitoring,
?
Fleisher ?L.A., Nelson ?A.H., Rosenbaum ?S.H..?Postoperative myocardial ischemia: etiology of cardiac morbidity or manifestation of underlying disease?,
?
Fuster ?V., Stein ?B., Ambrose ?J.A.. ?et al.??Atherosclerotic plaque rupture and thrombosis: evolving concepts,
?
Tuman ?K.J., McCarthy ?R.J., March ?R.J.. ?et al.??Effects of epidural anesthesia and analgesia on coagulation and outcome after major vascular surgery,
?
Ellis ?S.G., Hertzer ?N.R., Young ?J.R., Brener ?S..?Angiographic correlates of cardiac death and myocardial infarction complicating major nonthoracic vascular surgery,
?
Dawood ?M.M., Gutpa ?D.K., Southern ?J.. ?et al.??Pathology of fatal perioperative myocardial infarction: implications regarding pathophysiology and prevention,
?
Herzog ?C.A., Littrell ?K., Arko ?C.. ?et al.??Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction,
?
Sosnov ?J., Lessard ?D., Goldberg ?R.J.. ?et al.??Differential symptoms of acute myocardial infarction in patients with kidney disease: a community-wide perspective,
?
Almehmi ?A., Broce ?M., Wetmore ?J.B..?Silent myocardiac ischemia is more prevalent in CKD patients undergoing multi-vessel coronary angioplasty (abstr),
?
Young ?L.H., Wackers ?F.J., Chyun ?D.A.. ?et al.??Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial,
?
Reilly ?D.F., McNeely ?M.J., Doerner ?D.. ?et al.??Self-reported exercise tolerance and the risk of serious perioperative complications,
?
Bennett ?W.M., Kloster ?F., Rosch ?J.. ?et al.??Natural history of asymptomatic coronary arteriographic lesions in diabetic patients with end-stage renal disease,
?
Weinrauch ?L., D'Elia ?J.A., Healy ?R.W.. ?et al.??Asymptomatic coronary artery disease: angiographic assessment of diabetics evaluated for renal transplantation,
?
Braun ?W.E., Phillips ?D.F., Vidt ?D.G.. ?et al.??Coronary artery disease in 100 diabetics with end-stage renal failure,
?
Lorber ?M.I., Van Buren ?C.T., Flechner ?S.M.. ?et al.??Pretransplant coronary arteriography for diabetic renal transplant recipients,
?
Manske ?C.L., Wilson ?R.F., Wang ?Y., Thomas ?W..?Prevalence of, and risk factors for, angiographically determined coronary artery disease in type I-diabetic patients with nephropathy,
?
Ohtake ?T., Kobayashi ?S., Moriya ?H.. ?et al.??High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination,
?
Sharma ?R., Pellerin ?D., Gaze ?D.C.. ?et al.??Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates,
?
De Lima ?J.J., Sabbaga ?E., Vieira ?M.L.. ?et al.??Coronary angiography is the best predictor of events in renal transplant candidates compared with noninvasive testing,
?
Charytan ?D., Kuntz ?R.E., Mauri ?L., DeFilippi ?C..?Distribution of coronary artery disease and relation to mortality in asymptomatic hemodialysis patients,
?
Gowdak ?L.H., de Paula ?F.J., Cesar ?L.A.. ?et al.??Screening for significant coronary artery disease in high-risk renal transplant candidates,
?
Gowdak ?L.H., de Paula ?F.J., Cesar ?L.A.. ?et al.??Diabetes and coronary artery disease impose similar cardiovascular morbidity and mortality on renal transplant candidates,
?
Hage ?F.G., Smalheiser ?S., Zoghbi ?G.J.. ?et al.??Predictors of survival in patients with end-stage renal disease evaluated for kidney transplantation,
?
Hickson ?L.J., Cosio ?F.G., El-Zoghby ?Z.M.. ?et al.??Survival of patients on the kidney transplant wait list: relationship to cardiac troponin T,
?
Lentine ?K.L., Hurst ?F.P., Jindal ?R.M.. ?et al.??Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies,
?
Marwick ?T.H., Steinmuller ?D.R., Underwood ?D.A.. ?et al.??Ineffectiveness of dipyridamole single-photon emission computed tomography thallium imaging as a screening technique for coronary artery disease in patients with end-stage renal failure,
?
Boudreau ?R.J., Strony ?J.T., duCret ?R.P.. ?et al.??Perfusion thallium imaging of type I diabetes patients with end stage renal disease: comparison of oral and intravenous dipyridamole administration,
?
Vandenberg ?B.F., Rossen ?J.D., Grover-McKay ?M.. ?et al.??Evaluation of diabetic patients for renal and pancreas transplantation: noninvasive screening for coronary artery disease using radionuclide methods,
?
Dahan ?M., Viron ?B.M., Faraggi ?M.. ?et al.??Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients,
?
Herzog ?C.A., Marwick ?T.H., Pheley ?A.M.. ?et al.??Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates,
?
Worthley ?M.I., Unger ?S.A., Mathew ?T.H.. ?et al.??Usefulness of tachycardic-stress perfusion imaging to predict coronary artery disease in high-risk patients with chronic renal failure,
?
Ferreira ?P.A., de Lima ?V.C., Campos Filho ?O.. ?et al.??Feasibility, safety and accuracy of dobutamine/atropine stress echocardiography for the detection of coronary artery disease in renal transplant candidates,
?
Ragosta ?M., Samady ?H., Isaacs ?R.B.. ?et al.??Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries,
?
Morrow ?C.E., Schwartz ?J.S., Sutherland ?D.E.. ?et al.??Predictive value of thallium stress testing for coronary and cardiovascular events in uremic diabetic patients before renal transplantation,
?
Reis ?G., Marcovitz ?P.A., Leichtman ?A.B.. ?et al.??Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease,
?
Bates ?J.R., Sawada ?S.G., Segar ?D.S.. ?et al.??Evaluation using dobutamine stress echocardiography in patients with insulin-dependent diabetes mellitus before kidney and/or pancreas transplantation,
?
Tita ?C., Karthikeyan ?V., Stroe ?A.. ?et al.??Stress echocardiography for risk stratification in patients with end-stage renal disease undergoing renal transplantation,
?
Marwick ?T.H., Lauer ?M.S., Lobo ?A.. ?et al.??Use of dobutamine echocardiography for cardiac risk stratification of patients with chronic renal failure,
?
Rakhit ?D.J., Armstrong ?K.A., Beller ?E.. ?et al.??Risk stratification of patients with chronic kidney disease: results of screening strategies incorporating clinical risk scoring and dobutamine stress echocardiography,
?
Rabbat ?C.G., Treleaven ?D.J., Russell ?J.D.. ?et al.??Prognostic value of myocardial perfusion studies in patients with end-stage renal disease assessed for kidney or kidney-pancreas transplantation: a meta-analysis,
?
Bergeron ?S., Hillis ?G.S., Haugen ?E.N.. ?et al.??Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease,
?
Wong ?C.F., Little ?M.A., Vinjamuri ?S.. ?et al.??Technetium myocardial perfusion scanning in prerenal transplant evaluation in the United Kingdom,
?
?Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10?11 February 1998, Miami, Florida: American Diabetes Association,
?
Scognamiglio ?R., Negut ?C., Ramondo ?A.. ?et al.??Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus,
?
Haffner ?S.M., Lehto ?S., Ronnemaa ?T.. ?et al.??Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction,
?
Diamond ?G.A., Kaul ?S., Shah ?P.K..?Screen testing cardiovascular prevention in asymptomatic diabetic patients,
?
Aalten ?J., Hoogeveen ?E.K., Roodnat ?J.I.. ?et al.??Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death,
?
Kasiske ?B.L., Chakkera ?H.A., Roel ?J..?Explained and unexplained ischemic heart disease risk after renal transplantation,
?
Ducloux ?D., Kazory ?A., Chalopin ?J.M..?Predicting coronary heart disease in renal transplant recipients: a prospective study,
?
Kiberd ?B., Panek ?R..?Cardiovascular outcomes in the outpatient kidney transplant clinic: the Framingham risk score revisited,
?
Gaston ?R.S., Danovitch ?G.M., Adams ?P.L.. ?et al.??The report of a national conference on the wait list for kidney transplantation,
?
Inoguchi ?T., Yamashita ?T., Umeda ?F.. ?et al.??High incidence of silent myocardial ischemia in elderly patients with non insulin-dependent diabetes mellitus,
?
Hachamovitch ?R., Hayes ?S., Friedman ?J.D.. ?et al.??Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan?,
?
Hakeem ?A., Bhatti ?S., Dillie ?K.S.. ?et al.??Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death,
?
Rakhit ?D.J., Marwick ?T.H., Armstrong ?K.A.. ?et al.??Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease,
?
Gill ?J.S., Ma ?I., Landsberg ?D.. ?et al.??Cardiovascular events and investigation in patients who are awaiting cadaveric kidney transplantation,
?
Foley ?R.N., Parfrey ?P.S., Harnett ?J.D.. ?et al.??Clinical and echocardiographic disease in patients starting end-stage renal disease therapy,
?
Siedlecki ?A., Foushee ?M., Curtis ?J.J.. ?et al.??The impact of left ventricular systolic dysfunction on survival after renal transplantation,
?
de Mattos ?A.M., Siedlecki ?A., Gaston ?R.S.. ?et al.??Systolic dysfunction portends increased mortality among those waiting for renal transplant,
?
Yamada ?S., Ishii ?H., Takahashi ?H.. ?et al.??Prognostic value of reduced left ventricular ejection fraction at start of hemodialysis therapy on cardiovascular and all-cause mortality in end-stage renal disease patients,
?
Cice ?G., Ferrara ?L., D'Andrea ?A.. ?et al.??Carvedilol increases two-year survival in dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial,
?
Wali ?R.K., Wang ?G.S., Gottlieb ?S.S.. ?et al.??Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease,
?
Stokkel ?M., Duchateau ?C.S., Jukema ?W., de Fijter ?H.W..?Noninvasive assessment of left ventricular function prior to and 6 months after renal transplantation,
?
Lentine ?K.L., Xiao ?H., Brennan ?D.C.. ?et al.??The impact of kidney transplantation on heart failure risk varies with candidate body mass index,
?
Bonow ?R.O., Carabello ?B.A., Chatterjee ?K.. ?et al.??2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease),
?
Abbott ?K.C., Hshieh ?P., Cruess ?D.. ?et al.??Hospitalized valvular heart disease in patients on renal transplant waiting list: incidence, clinical correlates and outcomes,
?
Umana ?E., Ahmed ?W., Alpert ?M.A..?Valvular and perivalvular abnormalities in end-stage renal disease,
?
Mizutani ?K., Naruko ?T., Komatsu ?R., Ueda ?M..?Enhanced expression of neopterin in accumulated macrophages at aortic valve stenosis in patients with hemodialysis (abstr),
?
Melchor ?J.L., Gracida ?C., Orihuela ?O..?Improvement of mitral dysfunction after kidney transplantation,
?
?ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association: Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease),
?
Herzog ?C.A., Ma ?J.Z., Collins ?A.J..?Long-term survival of dialysis patients in the United States with prosthetic heart valves: should ACC/AHA practice guidelines on valve selection be modified?,
?
Sharma ?A., Gilbertson ?D.T., Herzog ?C.A..?Survival of kidney transplantation patients in the United States after cardiac valve replacement,
?
Zlotnick ?D.M., Axelrod ?D.A., Chobanian ?M.C.. ?et al.??Non-invasive detection of pulmonary hypertension prior to renal transplantation is a predictor of increased risk for early graft dysfunction,
?
Issa ?N., Krowka ?M.J., Griffin ?M.D.. ?et al.??Pulmonary hypertension is associated with reduced patient survival after kidney transplantation,
?
McLaughlin ?V.V., McGoon ?M.D..?Pulmonary arterial hypertension,
?
Rudski ?L.G., Lai ?W.W., Afilalo ?J.. ?et al.??Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography,
?
Rakhit ?D.J., Zhang ?X.H., Leano ?R.. ?et al.??Prognostic role of subclinical left ventricular abnormalities and impact of transplantation in chronic kidney disease,
?
Abe ?S., Yoshizawa ?M., Nakanishi ?N.. ?et al.??Electrocardiographic abnormalities in patients receiving hemodialysis,
?
Rajagopalan ?N., Miller ?T.D., Hodge ?D.O.. ?et al.??Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging,
?
Jaffe ?A.S., Babuin ?L., Apple ?F.S..?Biomarkers in acute cardiac disease: the present and the future,
?
Khan ?N.A., Hemmelgarn ?B.R., Tonelli ?M.. ?et al.??Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis [published correction appears in Circulation. 2006;113:e742],
?
Sharma ?R., Gaze ?D.C., Pellerin ?D.. ?et al.??Ischemia-modified albumin predicts mortality in ESRD,
?
Connolly ?G.M., Cunningham ?R., McNamee ?P.T.. ?et al.??Troponin T is an independent predictor of mortality in renal transplant recipients,
?
Hickson ?L.T., El-Zoghby ?Z.M., Lorenz ?E.C.. ?et al.??Patient survival after kidney transplantation: relationship to pretransplant cardiac troponin T levels,
?
Budoff ?M.J., Shaw ?L.J., Liu ?S.T.. ?et al.??Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients,
?
Raggi ?P., Boulay ?A., Chasan-Taber ?S.. ?et al.??Cardiac calcification in adult hemodialysis patients: a link between end-stage renal disease and cardiovascular disease?,
?
Braun ?J., Oldendorf ?M., Moshage ?W.. ?et al.??Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients,
?
Goodman ?W.G., Goldin ?J., Kuizon ?B.D.. ?et al.??Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis,
?
Oh ?J., Wunsch ?R., Turzer ?M.. ?et al.??Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure,
?
Matsuoka ?M., Iseki ?K., Tamashiro ?M.. ?et al.??Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis,
?
Greenland ?P., Bonow ?R.O., Brundage ?B.H.. ?et al.??ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography),
?
Haydar ?A.A., Hujairi ?N.M., Covic ?A.A.. ?et al.??Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography,
?
Sharples ?E.J., Pereira ?D., Summers ?S.. ?et al.??Coronary artery calcification measured with electron-beam computerized tomography correlates poorly with coronary artery angiography in dialysis patients,
?
Tong ?L.L., Mehrotra ?R., Shavelle ?D.M.. ?et al.??Poor correlation between coronary artery calcification and obstructive coronary artery disease in an end-stage renal disease patient,
?
Shroff ?R.C., McNair ?R., Figg ?N.. ?et al.??Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis,
?
Vanhoenacker ?P.K., Heijenbrok-Kal ?M.H., Van Heste ?R.. ?et al.??Diagnostic performance of multidetector CT angiography for assessment of coronary artery disease: meta-analysis,
?
Meijboom ?W.B., Weustink ?A.C., Pugliese ?F.. ?et al.??Comparison of diagnostic accuracy of 64-slice computed tomography coronary angiography in women versus men with angina pectoris,
?
Taylor ?A.J., Cerqueira ?M., Hodgson ?J.M.. ?et al.??ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance,
?
Manske ?C.L., Wang ?Y., Rector ?T.. ?et al.??Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure,
?
Kumar ?N., Baker ?C.S., Chan ?K.. ?et al.??Cardiac survival after pre-emptive coronary angiography in transplant patients and those awaiting transplantation,
?
Garcia ?S., Moritz ?T.E., Ward ?H.B.. ?et al.??Usefulness of revascularization of patients with multivessel coronary artery disease before elective vascular surgery for abdominal aortic and peripheral occlusive disease,
?
Smith ?S.C., Feldman ?T.E., Hirshfeld ?J.W.. ?et al.??ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention?summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention),
?
Anderson ?J.L., Adams ?C.D., Antman ?E.M.. ?et al.??2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,
?
Levine ?G.N., Bates ?E.R., Blankenship ?J.C.. ?et al.??2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions,
?
Szczech ?L.A., Reddan ?D.N., Owen ?W.F.. ?et al.??Differential survival after coronary revascularization procedures among patients with renal insufficiency,
?
Reddan ?D.N., Szczech ?L.A., Tuttle ?R.H.. ?et al.??Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery disease,
?
Hemmelgarn ?B.R., Southern ?D., Culleton ?B.F.. ?et al.??Survival after coronary revascularization among patients with kidney disease,
?
Herzog ?C.A., Ma ?J.Z., Collins ?A.J..?Long-term outcome of renal transplant recipients in the United States after coronary revascularization procedures,
?
Herzog ?C.A., Solid ?C.A..?Long-term survival of U.S. dialysis patients after surgical bypass or percutaneous coronary stent placement in the drug-eluting stent era (abstr),
?
Ashrith ?G., Elayda ?M.A., Wilson ?J.M..?Revascularization options in patients with chronic kidney disease,
?
Flaherty ?J.D., Davidson ?C.J..?Diabetes and coronary revascularization,
?
Hlatky ?M.A., Boothroyd ?D.B., Bravata ?D.M.. ?et al.??Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials,
?
Malenka ?D.J., Leavitt ?B.J., Hearne ?M.J.. ?et al.??Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northern New England,
?
McCullough ?P.A., Adam ?A., Becker ?C.R.. ?et al.??Risk prediction of contrast-induced nephropathy,
?
Tan ?N., Liu ?Y., Zhou ?Y.L.. ?et al.??Contrast medium volume to creatinine clearance ratio: a predictor of contrast-induced nephropathy in the first 72 hours following percutaneous coronary intervention,
?
Kumar ?N., Dahri ?L., Brown ?W.. ?et al.??Effect of elective coronary angiography on glomerular filtration rate in patients with advanced chronic kidney disease,
?
Lorenz ?E.C., Stegall ?M.D., Cosio ?F.G.. ?et al.??The effect of coronary angiography on renal function in preemptive renal transplant candidates,
?
Brilakis ?E.S., Orford ?J.L., Fasseas ?P.. ?et al.??Outcome of patients undergoing balloon angioplasty in the two months prior to noncardiac surgery,
?
Wilson ?S.H., Rihal ?C.S., Bell ?M.R.. ?et al.??Timing of coronary stent thrombosis in patients treated with ticlopidine and aspirin,
?
Berger ?P.B., Bell ?M.R., Hasdai ?D.. ?et al.??Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement,
?
Nuttall ?G.A., Brown ?M.J., Stombaugh ?J.W.. ?et al.??Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention,
?
Rabbitts ?J.A., Nuttall ?G.A., Brown ?M.J.. ?et al.??Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents,
?
van Kuijk ?J.P., Flu ?W.J., Schouten ?O.. ?et al.??Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents,
?
Anwaruddin ?S., Askari ?A.T., Saudye ?H.. ?et al.??Characterization of post-operative risk associated with prior drug-eluting stent use,
?
Cutlip ?D.E., Windecker ?S., Mehran ?R.. ?et al.??Clinical end points in coronary stent trials: a case for standardized definitions,
?
Grines ?C.L., Bonow ?R.O., Casey ?D.E.. ?et al.??Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians,
?
Eisenberg ?M.J., Richard ?P.R., Libersan ?D., Filion ?K.B..?Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents,
?
Kidney Disease Outcomes Quality Initiative (K/DOQI), ?K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease,
?
Levin ?N.W., Kotanko ?P., Eckardt ?K.U.. ?et al.??Blood pressure in chronic kidney disease stage 5D: report from a Kidney Disease: Improving Global Outcomes controversies conference,
?
Davenport ?A., Cox ?C., Thuraisingham ?R..?Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension,
?
Agarwal ?R., Metiku ?T., Tegegne ?G.G.. ?et al.??Diagnosing hypertension by intradialytic blood pressure recordings,
?
Agarwal ?R., Peixoto ?A.J., Santos ?S.F., Zoccali ?C..?Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure,
?
Agarwal ?R., Andersen ?M.J., Bishu ?K., Saha ?C..?Home blood pressure monitoring improves the diagnosis of hypertension in hemodialysis patients,
?
Agarwal ?R., Brim ?N.J., Mahenthiran ?J.. ?et al.??Out-of-hemodialysis-unit blood pressure is a superior determinant of left ventricular hypertrophy,
?
Alborzi ?P., Patel ?N., Agarwal ?R..?Home blood pressures are of greater prognostic value than hemodialysis unit recordings,
?
Agarwal ?R., Andersen ?M.J..?Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease,
?
Kalantar-Zadeh ?K., Block ?G., Humphreys ?M.H., Kopple ?J.D..?Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients,
?
Heerspink ?H.J., Ninomiya ?T., Zoungas ?S.. ?et al.??Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials,
?
Agarwal ?R., Alborzi ?P., Satyan ?S., Light ?R.P..?Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial,
?
Berl ?T., Hunsicker ?L.G., Lewis ?J.B.. ?et al.??Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy,
?
Mann ?J.F., Gerstein ?H.C., Pogue ?J.. ?et al.??Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial,
?
Zannad ?F., Kessler ?M., Lehert ?P.. ?et al.??Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies,
?
Suzuki ?H., Kanno ?Y., Sugahara ?S.. ?et al.??Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial,
?
Collins ?A.J., Foley ?R., Herzog ?C.. ?et al.??Excerpts from the United States Renal Data System 2007 annual data report,
?
Culleton ?B.F., Walsh ?M., Klarenbach ?S.W.. ?et al.??Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial,
?
Kidney Disease Outcomes Quality Initiative (K/DOQI) Group, ?K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease,
?
Chobanian ?A.V., Bakris ?G.L., Black ?H.R.. ?et al.??The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure,
?
Avram ?M.M., Bonomini ?L.V., Sreedhara ?R., Mittman ?N..?Predictive value of nutritional markers (albumin, creatinine, cholesterol, and hematocrit) for patients on dialysis for up to 30 years,
?
Iseki ?K., Yamazato ?M., Tozawa ?M., Takishita ?S..?Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients,
?
Kalantar-Zadeh ?K., Kopple ?J.D., Block ?G., Humphreys ?M.H..?A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients,
?
Gamba ?G., Mejia ?J.L., Saldivar ?S.. ?et al.??Death risk in CAPD patients: the predictive value of the initial clinical and laboratory variables,
?
Liu ?Y., Coresh ?J., Eustace ?J.A.. ?et al.??Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition,
?
Seliger ?S.L., Weiss ?N.S., Gillen ?D.L.. ?et al.??HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients,
?
Goldfarb-Rumyantzev ?A.S., Habib ?A.N., Baird ?B.C.. ?et al.??The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis,
?
Mason ?N.A., Bailie ?G.R., Satayathum ?S.. ?et al.??HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients,
?
Robson ?R., Collins ?J., Johnson ?R.. ?et al.??Effects of simvastatin and enalapril on serum lipoprotein concentrations and left ventricular mass in patients on dialysis: the Perfect Study Collaborative Group,
?
Chang ?J.W., Yang ?W.S., Min ?W.K.. ?et al.??Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients,
?
Harris ?K.P., Wheeler ?D.C., Chong ?C.C..?A placebo-controlled trial examining atorvastatin in dyslipidemic patients undergoing CAPD,
?
Saltissi ?D., Morgan ?C., Rigby ?R.J., Westhuyzen ?J..?Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis,
?
Lins ?R.L., Matthys ?K.E., Billiouw ?J.M.. ?et al.??Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: a placebo-controlled study,
?
Diepeveen ?S.H., Verhoeven ?G.W., Van Der Palen ?J.. ?et al.??Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial,
?
Baigent ?C., Landray ?M., Leaper ?C.. ?et al.??First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease,
?
Ichihara ?A., Hayashi ?M., Ryuzaki ?M.. ?et al.??Fluvastatin prevents development of arterial stiffness in haemodialysis patients with type 2 diabetes mellitus,
?
Kidney Disease Outcomes Quality Initiative (K/DOQI) Group, ?K/DOQI clinical practice guidelines for managing dyslipidemias in chronic kidney disease,
?
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, ?Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III),
?
Stegmayr ?B.G., Brannstrom ?M., Bucht ?S.. ?et al.??Low-dose atorvastatin in severe chronic kidney disease patients: a randomized, controlled endpoint study,
?
Wanner ?C., Krane ?V., Marz ?W.. ?et al.??Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis,
?
Fellstrom ?B.C., Jardine ?A.G., Schmieder ?R.E.. ?et al.??Rosuvastatin and cardiovascular events in patients undergoing hemodialysis,
?
Colhoun ?H.M., Betteridge ?D.J., Durrington ?P.N.. ?et al.??Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial,
?
Baigent ?C., Landray ?M.J., Reith ?C.. ?et al.??The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial,
?
Strippoli ?G.F., Navaneethan ?S.D., Johnson ?D.W.. ?et al.??Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials,
?
Collins ?R., Armitage ?J., Parish ?S.. ?et al.??Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions,
?
Welten ?G.M., Chonchol ?M., Hoeks ?S.E.. ?et al.??Beta-blockers improve outcomes in kidney disease patients having noncardiac vascular surgery,
?
Mangano ?D.T., Layug ?E.L., Wallace ?A., Tateo ?I..?Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery: Multicenter Study of Perioperative Ischemia Research Group,
?
Poldermans ?D., Boersma ?E., Bax ?J.J.. ?et al.??The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery: Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group [see comments],
?
Lindenauer ?P.K., Pekow ?P., Wang ?K.. ?et al.??Perioperative beta-blocker therapy and mortality after major noncardiac surgery,
?
Yang ?H., Raymer ?K., Butler ?R.. ?et al.??The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial,
?
Juul ?A.B., Wetterslev ?J., Gluud ?C.. ?et al.??Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial,
?
Devereaux ?P.J., Yang ?H., Yusuf ?S.. ?et al.??Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial,
?
Dunkelgrun ?M., Boersma ?E., Schouten ?O.. ?et al.??Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: a randomized controlled trial (DECREASE-IV),
?
Fleisher ?L.A., Beckman ?J.A., Brown ?K.A.. ?et al.??2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery,
?
Ciapetti ?M., di Valvasone ?S., di Filippo ?A.. ?et al.??Low-dose dopamine in kidney transplantation,
?
Schnuelle ?P., Gottmann ?U., Hoeger ?S.. ?et al.??Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial,
?
Ruilope ?L.M., Salvetti ?A., Jamerson ?K.. ?et al.??Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) study,
?
Jardine ?M.J., Ninomiya ?T., Perkovic ?V.. ?et al.??Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial,
?
Berger ?A.K., Duval ?S., Krumholz ?H.M..?Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction,
?
McCullough ?P.A., Sandberg ?K.R., Borzak ?S.. ?et al.??Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease,
?
Durazzo ?A.E., Machado ?F.S., Ikeoka ?D.T.. ?et al.??Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial,
?
Schouten ?O., Boersma ?E., Hoeks ?S.E.. ?et al.??Fluvastatin and perioperative events in patients undergoing vascular surgery,
?
Le Manach ?Y., Godet ?G., Coriat ?P.. ?et al.??The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery,
?
Pittas ?A.G., Siegel ?R.D., Lau ?J..?Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials,
?
Gandhi ?G.Y., Murad ?M.H., Flynn ?D.N.. ?et al.??Effect of perioperative insulin infusion on surgical morbidity and mortality: systematic review and meta-analysis of randomized trials,
?
Thomas ?G., Rojas ?M.C., Epstein ?S.K.. ?et al.??Insulin therapy and acute kidney injury in critically ill patients: a systematic review,
?
Finfer ?S., Chittock ?D.R., Su ?S.Y.. ?et al.??Intensive versus conventional glucose control in critically ill patients,
?
Holdaas ?H., Fellstrom ?B., Jardine ?A.G.. ?et al.??Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial,
?
Holdaas ?H., Fellstrom ?B., Cole ?E.. ?et al.??Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study,
?
Jardine ?A.G., Holdaas ?H., Fellstrom ?B.. ?et al.??Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: post-hoc subgroup analyses of the ALERT Study,
?
Holdaas ?H., Fellstrom ?B., Jardine ?A.G.. ?et al.??Beneficial effect of early initiation of lipid-lowering therapy following renal transplantation,
?
Martinez Hernandez ?B.E., Persaud ?J.W., Varghese ?Z., Moorhead ?J.F..?Low-dose simvastatin is safe in hyperlipidaemic renal transplant patients,
?
Arnadottir ?M., Eriksson ?L.O., Germershausen ?J.I., Thysell ?H..?Low-dose simvastatin is a well-tolerated and efficacious cholesterol-lowering agent in ciclosporin-treated kidney transplant recipients: double-blind, randomized, placebo-controlled study in 40 patients,
?
Lepre ?F., Rigby ?R., Hawley ?C.. ?et al.??A double-blind placebo controlled trial of simvastatin for the treatment of dyslipidaemia in renal allograft recipients,
?
Renders ?L., Mayer-Kadner ?I., Koch ?C.. ?et al.??Efficacy and drug interactions of the new HMG-CoA reductase inhibitors cerivastatin and atorvastatin in CsA-treated renal transplant recipients,
?
Santos ?A.F., Keitel ?E., Bittar ?A.E.. ?et al.??Safety and efficacy of simvastatin for hyperlipidemia in renal transplant recipients: a double-blind, randomized, placebo-controlled study,
?
Katznelson ?S., Wilkinson ?A.H., Kobashigawa ?J.A.. ?et al.??The effect of pravastatin on acute rejection after kidney transplantation: a pilot study,
?
Tuncer ?M., Suleymanlar ?G., Ersoy ?F.F., Yakupoglu ?G..?Comparison of the effects of simvastatin and pravastatin on acute rejection episodes in renal transplant patients,
?
Kasiske ?B.L., Heim-Duthoy ?K.L., Singer ?G.G.. ?et al.??The effects of lipid-lowering agents on acute renal allograft rejection,
?
Holdaas ?H., Jardine ?A.G., Wheeler ?D.C.. ?et al.??Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial,
?
Sahu ?K., Sharma ?R., Gupta ?A.. ?et al.??Effect of lovastatin, an HMG CoA reductase inhibitor, on acute renal allograft rejection,
?
Seron ?D., Oppenheimer ?F., Pallardo ?L.M.. ?et al.??Fluvastatin in the prevention of renal transplant vasculopathy: results of a prospective, randomized, double-blind, placebo-controlled trial,
?
Hausberg ?M., Kosch ?M., Stam ?F.. ?et al.??Effect of fluvastatin on endothelium-dependent brachial artery vasodilation in patients after renal transplantation,
?
Cofan ?F., Gilabert ?R., Zambon ?D.. ?et al.??Effect of pravastatin treatment on the evolution of extracoronary atherosclerosis in renal transplant patients,
?
Kosch ?M., Barenbrock ?M., Suwelack ?B.. ?et al.??Effect of a 3-year therapy with the 3-hydroxy-3-methylglutaryl coenzyme A reductase-inhibitor fluvastatin on endothelial function and distensibility of large arteries in hypercholesterolemic renal transplant recipient,
?
Asberg ?A., Holdaas ?H., Jardine ?A.G.. ?et al.??Fluvastatin reduces atherogenic lipids without any effect on native endothelial function early after kidney transplantation,
?
Wiesbauer ?F., Heinze ?G., Mitterbauer ?C.. ?et al.??Statin use is associated with prolonged survival of renal transplant recipients,
?
Cannon ?C.P., Braunwald ?E., McCabe ?C.H.. ?et al.??Intensive versus moderate lipid lowering with statins after acute coronary syndromes,
?
de Lemos ?J.A., Blazing ?M.A., Wiviott ?S.D.. ?et al.??Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial,
?
Koren ?M.J., Hunninghake ?D.B..ALLIANCE Investigators, ?Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the ALLIANCE study,
?
LaRosa ?J.C., Grundy ?S.M., Waters ?D.D.. ?et al.??Intensive lipid lowering with atorvastatin in patients with stable coronary disease,
?
Ridker ?P.M., Danielson ?E., Fonseca ?F.A.. ?et al.??Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein,
?
Puthenparumpil ?J.J., Keough-Ryan ?T., Kiberd ?M.. ?et al.??Treatment of hypercholesterolemia with ezetimibe in the kidney transplant population,
?
Buchanan ?C., Smith ?L., Corbett ?J.. ?et al.??A retrospective analysis of ezetimibe treatment in renal transplant recipients,
?
Kohnle ?M., Pietruck ?F., Kribben ?A.. ?et al.??Ezetimibe for the treatment of uncontrolled hypercholesterolemia in patients with high-dose statin therapy after renal transplantation,
?
Langone ?A.J., Chuang ?P..?Ezetimibe in renal transplant patients with hyperlipidemia resistant to HMG-CoA reductase inhibitors,
?
Kasiske ?B., Cosio ?F.G., Beto ?J.. ?et al.??Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative,
?
Fellstrom ?B., Holdaas ?H., Jardine ?A.G.. ?et al.??Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial,
?
Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group, ?KDIGO clinical practice guideline for the care of kidney transplant recipients,
?
Schrier ?R.W., Arroyo ?V., Bernardi ?M.. ?et al.??Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis,
?
Murray ?K.F., Carithers ?R.L..AASLD, ?AASLD practice guidelines: evaluation of the patient for liver transplantation,
?
McDonnell ?P.J., Toye ?P.A., Hutchins ?G.M..?Primary pulmonary hypertension and cirrhosis: are they related?,
?
Auletta ?M., Oliviero ?U., Iasiuolo ?L.. ?et al.??Pulmonary hypertension associated with liver cirrhosis: an echocardiographic study,
?
Ramsay ?M.A., Simpson ?B.R., Nguyen ?A.T.. ?et al.??Severe pulmonary hypertension in liver transplant candidates,
?
Krowka ?M.J., Mandell ?M.S., Ramsay ?M.A.. ?et al.??Hepatopulmonary syndrome and portopulmonary hypertension: a report of the Multicenter Liver Transplant Database,
?
Swanson ?K.L., Wiesner ?R.H., Nyberg ?S.L.. ?et al.??Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups,
?
Ashfaq ?M., Chinnakotla ?S., Rogers ?L.. ?et al.??The impact of treatment of portopulmonary hypertension on survival following liver transplantation,
?
Colle ?I.O., Moreau ?R., Godinho ?E.. ?et al.??Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study,
?
Kim ?W.R., Krowka ?M.J., Plevak ?D.J.. ?et al.??Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates,
?
Torregrosa ?M., Genesca ?J., Gonzalez ?A.. ?et al.??Role of Doppler echocardiography in the assessment of portopulmonary hypertension in liver transplantation candidates,
?
Cotton ?C.L., Gandhi ?S., Vaitkus ?P.T.. ?et al.??Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates,
?
Hoeper ?M.M., Krowka ?M.J., Strassburg ?C.P..?Portopulmonary hypertension and hepatopulmonary syndrome,
?
Porres-Aguilar ?M., Zuckerman ?M.J., Figueroa-Casas ?J.B., Krowka ?M.J..?Portopulmonary hypertension: state of the art,
?
Abbas ?A.E., Fortuin ?F.D., Schiller ?N.B.. ?et al.??A simple method for noninvasive estimation of pulmonary vascular resistance,
?
Rollan ?M.J., Munoz ?A.C., Perez ?T., Bratos ?J.L..?Value of contrast echocardiography for the diagnosis of hepatopulmonary syndrome,
?
Vedrinne ?J.M., Duperret ?S., Bizollon ?T.. ?et al.??Comparison of transesophageal and transthoracic contrast echocardiography for detection of an intrapulmonary shunt in liver disease,
?
Hemnes ?A.R., Robbins ?I.M..?Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantation,
?
Melgosa ?M.T., Ricci ?G.L., Garcia-Pagan ?J.C.. ?et al.??Acute and long-term effects of inhaled iloprost in portopulmonary hypertension,
?
Keeffe ?E.B..?Liver transplantation at the millennium: past, present, and future,
?
Carey ?W.D., Dumot ?J.A., Pimentel ?R.R.. ?et al.??The prevalence of coronary artery disease in liver transplant candidates over age 50,
?
Morris ?J.J., Hellman ?C.L., Gawey ?B.J.. ?et al.??Case 3?1995: three patients requiring both coronary artery bypass surgery and orthotopic liver transplantation,
?
Plotkin ?J.S., Benitez ?R.M., Kuo ?P.C.. ?et al.??Dobutamine stress echocardiography for preoperative cardiac risk stratification in patients undergoing orthotopic liver transplantation,
?
Donovan ?C.L., Marcovitz ?P.A., Punch ?J.D.. ?et al.??Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation,
?
Tiukinhoy-Laing ?S.D., Rossi ?J.S., Bayram ?M.. ?et al.??Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation,
?
Plotkin ?J.S., Scott ?V.L., Pinna ?A.. ?et al.??Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation,
?
Davidson ?C.J., Gheorghiade ?M., Flaherty ?J.D.. ?et al.??Predictive value of stress myocardial perfusion imaging in liver transplant candidates,
?
Williams ?K., Lewis ?J.F., Davis ?G., Geiser ?E.A..?Dobutamine stress echocardiography in patients undergoing liver transplantation evaluation,
?
Bradley ?S.M., Soine ?L.A., Caldwell ?J.H., Goldberg ?S.L..?Screening stress myocardial perfusion imaging and eligibility for liver transplantation,
?
McAvoy ?N.C., Kochar ?N., McKillop ?G.. ?et al.??Prevalence of coronary artery calcification in patients undergoing assessment for orthotopic liver transplantation,
?
Budoff ?M.J., Achenbach ?S., Blumenthal ?R.S.. ?et al.??Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology,
?
Sharma ?M., Yong ?C., Majure ?D.. ?et al.??Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation,
?
Bizouarn ?P., Ausseur ?A., Desseigne ?P.. ?et al.??Early and late outcome after elective cardiac surgery in patients with cirrhosis,
?
Klemperer ?J.D., Ko ?W., Krieger ?K.H.. ?et al.??Cardiac operations in patients with cirrhosis,
?
Filsoufi ?F., Salzberg ?S.P., Rahmanian ?P.B.. ?et al.??Early and late outcome of cardiac surgery in patients with liver cirrhosis,
?
Axelrod ?D., Ko
Source: http://content.onlinejacc.org/article.aspx?articleID=1212276
tri international criminal court ios 5.1 apple tv update new ipad release pregnant jessica simpson international womens day
Tons of backlinks utilising a wordpress plugin link for your blog.Turbo charge the surfer experience by means of a SEOPressor free 
We are not the FHA, VA, USDA, HUD or any other government organization. The content on this blog is intended for information purposes only. 
